Newsletter

226950 - Olix Pharmaceuticals, Inc.

226950 Summary
Biopharma
Stock Price & Overview
₩95,900 +4,100 (+4.47%) Close · Sep 4, 2026 KST
KOSDAQ | ₩KRW | Close: ₩95,900  ≈ US$69  ·  Market cap ₩2.0tn (≈ $1.4bn)
Home › 226950 › Filings

Resolution to convene an extraordinary general meeting

DART
Olix Pharmaceuticals, Inc.
Filed Jul 15, 2026 KST · Filing · receipt 20260715900484

kstock has not written this one up. The title above is a translation of the Korean form name; the filing itself is on DART, in Korean.

Read the original on DART ↗ Korean. DART is Korea's electronic disclosure system, run by the Financial Supervisory Service — the filing equivalent of EDGAR.
Korean form name: 주주총회소집결의 (임시주주총회)

226950

Price
₩95,900
Change
+4.47%
Market cap
₩2.0tn
Prev. close
₩91,800
226950 SummaryCompare to Peers

More 226950 filings

Exercise of a conversion right on convertible shares

09/01/26

5% Ownership Report — Short Form

09/01/26

Exercise of a conversion right on convertible shares

08/31/26

Insider / Major Shareholder Holdings Report

08/28/26

Material matter affecting investment judgment

08/21/26

Half-Year Report

08/14/26